AACR Annual Meeting 2018

April 14 - 18, 2018
Chicago, USA

Meinolf Thiemann, Ph.D., Director Assay Development
Christian Merz, Ph.D., Head of Cellular Analytics
Julian Sefrin, Ph.D., Senior Scientist

Poster Presentations:
"The novel hexavalent human CD137/4-1BB agonist HERA-CD137L promotes anti-cancer immunity by activating CD8 T cells while regulatory T cells are not affected" – Dr. Thiemann
"The hexavalent CD40 agonist HERA-CD40L augments multi-level crosstalk between T cells and antigen-presenting cells" – Dr. Merz
"The novel hexavalent HVEM agonist HERA-LIGHT promotes T cell activation and expansion" – Dr. Sefrin


14th Annual PEGS Boston

April 30 - May 4, 2018
Boston, USA

Oliver Hill, Ph.D., VP Molecular Biology
Karl Heinonen, M.Sc., Laboratory Head of Protein Production

Presentation by Oliver Hill, Ph.D.: May 4, 9:05 am EDT
"HERA: Engineering Next Generation TNFR-SF Agonists for Cancer Immunotherapy"